<DOC>
	<DOCNO>NCT01129271</DOCNO>
	<brief_summary>Primary objective : - Investigate potential food effect Adenosine diphosphate ( ADP ) -induced platelet aggregation 5-day repeated dos clopidogrel ( 300 mg load dose follow 4 day 75 mg/day ) healthy subject Secondary objective investigate potential food effect : - ADP-induced platelet aggregation 300 mg load dose clopidogrel - Pharmacokinetic profile clopidogrel active metabolite 5-day repeat dos clopidogrel</brief_summary>
	<brief_title>Food Effect Study Pharmacodynamic Bioavailability Clopidogrel 300/75 mg Healthy Subjects</brief_title>
	<detailed_description>The total duration per subject 8-9 week break follow : - Screening : 2 21 day first dose - Fed period : 7 day include 5 treatment day - Washout : least 14 day last dosing - Fasted period : 7 day include 5 treatment day - End study : 7 10 day last dosing</detailed_description>
	<mesh_term>Clopidogrel</mesh_term>
	<mesh_term>Ticlopidine</mesh_term>
	<criteria>Healthy male subject : determine medical history , physical examination include vital sign clinical laboratory test body weight 50kg 95 kg Body Mass Index ( BMI ) 18 30 kg/m2 Evidence inherit disorder coagulation/hemostasis function Smoking 5 cigarette equivalent per day Abnormal hemostasis screen Any contraindication clopidogrel Unability abstain intake drug affect haemostasis throughout whole study duration The information intend contain consideration relevant patient 's potential participation clinical trial .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2011</verification_date>
</DOC>